<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335352">
  <stage>Registered</stage>
  <submitdate>8/04/2010</submitdate>
  <approvaldate>12/04/2010</approvaldate>
  <actrnumber>ACTRN12610000291088</actrnumber>
  <trial_identification>
    <studytitle>effect of alpha lipoic acid on cardiac autonomic function and platelet reactivity  in type I  diabetes</studytitle>
    <scientifictitle>In patients with type I diabetes is alpha lipoic acid  better than placebo  for improvement of cardiac autonomic function and reduction of platelet reactivity?</scientifictitle>
    <utrn />
    <trialacronym>AUTO-REACT trial</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cardiovascular autonomic neuropathy in type I diabetes</healthcondition>
    <healthcondition>increased platelet reactivity in Type I diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>alpha lipoic acid
dose: 800 mg once per day
duration of administration: 4 weeks
mode of administration: oral capsules</interventions>
    <comparator>placebo
type: 800 mg microcellulose pill
frequency and duration of administration: once daily for 4 weeks
mode of administration: oral capsules</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>platelet reactivity
assessment method:  platelet function analyser system [PFA-100] method and flow cytometry.</outcome>
      <timepoint>at baseline and 4 weeks  following randomisation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>cardiac autonomic function
assessment method: heart rate variability</outcome>
      <timepoint>at baseline  and  4 weeks following randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>C-reactive protein
assessment method: blood analysis</outcome>
      <timepoint>at baseline and 4 weeks following randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>type I diabetes</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>cardiac ischemia
inflammatory diseases
neoplastic and hematologic diseases</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>1/12/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Rome</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Catholic University</primarysponsorname>
    <primarysponsoraddress>Largo A. Gemelli 8
00168 Rome</primarysponsoraddress>
    <primarysponsorcountry>Italy</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Department of Cardiology Catholic University</fundingname>
      <fundingaddress>Largo A. Gemelli 8
00168 Rome</fundingaddress>
      <fundingcountry>Italy</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The present randomized study will evaluate the effect of alpha lipoic acid compared to placebo on cardiac autonomic function and platelet reactivity in type I diabetic patients</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Catholic University Ethics Committee</ethicname>
      <ethicaddress>Largo A. Gemelli 8
00168 Rome</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Italy</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Giuseppe Scavone</name>
      <address>Largo A. Gemelli 8
00168 Rome</address>
      <phone>+39 063015 4071</phone>
      <fax />
      <email>jekoide80@yahoo.it</email>
      <country>Italy</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Eliano Navarese</name>
      <address>Largo A. Gemelli 8
00168 Rome</address>
      <phone>+39 06 3015 4187</phone>
      <fax />
      <email>eliano.navarese@alice.it</email>
      <country>Italy</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>